Q2 2026 13F · SEC CIK 1730145

Voss Capital, LP

Asset managerFiled 2026-08-14 for Q2 2026. Open the filing ↗ · All SEC filings ↗

Reported 13F value: $2.0B
Reported positions: 35
Top holdings a year, 3 yrs: +20.8%
Assets under management: $1.9B

Voss Capital, LP is an asset manager that reported 35 positions worth $2.0B in its Q2 2026 13F, filed 2026-08-14. Its largest holdings were Flywire Corporation (FLYW, 12.0%), Sempra (SRE, 9.4%), Cellebrite Di Ltd (CLBT, 8.3%). A portfolio copying its top holdings returned 20.8% a year over the last 3 years, against 22.3% for the S&P 500.

Voss Capital, LP holdings all 35 positions.

Weights are shares of the filer's total reported 13F value, compared with Q1 2026. Share changes may reflect splits; weight changes also reflect price moves. A 13F shows long US-listed positions only, up to 135 days after the fact.

Voss Capital, LP 13F holdings
Stock	% of 13F value	Q1 2026	Shares	Share change	Reported value
FLYWFlywire Corporation	12.0%	9.1%	13,629,500	+0.0%	$239.5M
SRESempra	9.4%	7.0%	2,036,737	+62.3%	$188.8M
CLBTCellebrite Di Ltd	8.3%	7.6%	11,441,874	+18.3%	$167.1M
GFFGriffon Corp	7.4%	7.6%	1,516,857	-16.9%	$147.9M
FIVNFive9 Inc	5.2%	5.1%	4,865,000	-16.5%	$103.7M
SHCSotera Health Co	5.2%	4.0%	5,825,000	+19.6%	$103.4M
PARPar Technology Corp	5.2%	3.7%	5,925,000	+21.4%	$103.2M
CHHChoice Hotels Intl Inc	5.0%	5.7%	910,000	-5.9%	$100.3M
SNSharkninja Inc	4.8%	4.2%	630,000	-9.4%	$95.9M
PRKSUnited Parks & Resorts Inc	4.0%	3.2%	1,670,000	-2.6%	$79.7M
LRNStride Inc	3.8%	4.3%	885,605	+4.2%	$76.4M
CSRCenterspace	3.5%	2.6%	1,230,000	+53.5%	$69.1M
TDOCTeladoc Health Inc	3.4%	1.3%	8,046,679	+91.6%	$68.2M
TTAMTitan America SA	2.7%	2.5%	2,925,000	-0.8%	$54.6M
RXTRackspace Technology Inc	2.5%	New	7,593,772	—	$49.6M
EEFTEuronet Worldwide Inc	2.5%	6.0%	675,000	-57.1%	$49.4M
XPOFXponential Fitness Inc	2.4%	2.2%	6,795,956	+5.2%	$47.0M
VGNTVersigent PLC	2.1%	New	1,007,203	—	$42.3M
GENIGenius Sports Limited	2.1%	3.3%	6,850,000	-47.6%	$41.5M
PKPark Hotels & Resorts Inc Com	1.5%	1.0%	2,160,000	+30.9%	$30.8M
AVTRAvantor Inc	1.3%	2.0%	2,650,000	-40.4%	$26.2M
CELHCelsius Holding Inc.	1.2%	2.4%	825,000	-31.5%	$24.2M
QUREUniqure NV	1.0%	0.6%	450,361	-25.6%	$20.7M
PHINPhinia Inc	1.0%	3.6%	243,317	-73.6%	$20.0M
LEGHLegacy Housing Corp	0.8%	0.7%	597,117	-0.5%	$15.7M
LGIHLgi Homes Inc	0.4%	1.1%	125,000	-74.7%	$8.0M
ALTGAlta Equipment Group Inc	0.4%	0.7%	1,176,515	-51.5%	$7.6M
POWLPowell Inds Inc	0.3%	4.2%	20,000	-85.3%	$5.7M
RNTXRein Therapeutics Inc	0.3%	0.3%	5,261,921	+19.9%	$5.5M
CCSCentury Communities Inc	0.2%	0.7%	45,210	-79.2%	$3.2M
ACTUActuate Therapeutics Inc	0.1%	0.3%	1,725,000	+0.0%	$2.6M
PEBPebblebrook Hotel Tr	0.1%	0.7%	100,000	-89.3%	$1.9M
SEERSeer Inc	0.0%	New	137,291	—	$228K
RDZNRoadzen Inc	0.0%	New	144,254	—	$211K
CGTXCognition Therapeutics Inc	0.0%	0.0%	175,000	-12.5%	$201K

What Voss Capital, LP bought and sold in Q2 2026, against Q1 2026.

New positions

Share counts compared with the Q1 2026 13F; a split also changes share counts.

How the holdings did against the S&P 500.

1 year: +10.9% /yr; S&P 500 +11.7%
3 years: +20.8% /yr; S&P 500 +22.3%
5 years: +12.8% /yr; S&P 500 +10.6%

A portfolio of the filer's 20 largest 13F positions, weighted by value, bought the trading day after each 13F was filed and held until the next one was: what copying this filer could have earned. 13Fs show long US-listed positions only, so this is an estimate of the stock picks, not the fund's reported returns.

Reported 13F value by quarter.

13F value by quarter
Quarter	13F value	Positions
Q2 2026	$2.0B	35
Q1 2026	$1.7B	39
Q4 2025	$1.9B	48
Q3 2025	$1.7B	46
Q2 2025	$1.5B	54
Q1 2025	$1.3B	56
Q4 2024	$1.3B	45
Q3 2024	$1.2B	39
Q2 2024	$1.0B	38
Q1 2024	$1.2B	33
Q4 2023	$1.0B	40
Q3 2023	$795.2M	41

Questions about Voss Capital, LP's portfolio

What stocks does Voss Capital, LP own?

Voss Capital, LP's latest 13F, for Q2 2026 and filed Aug 14, 2026, lists 35 positions worth $2.0B. The largest are Flywire Corporation (FLYW) at 12.0%, Sempra (SRE) at 9.4%, Cellebrite Di Ltd (CLBT) at 8.3%, Griffon Corp (GFF) at 7.4% and Five9 Inc (FIVN) at 5.2%.

What did Voss Capital, LP buy last quarter?

In Q2 2026, Voss Capital, LP added a new position in Rackspace Technology Inc (RXT), a new position in Versigent PLC (VGNT), a new position in Seer Inc (SEER), a new position in Roadzen Inc (RDZN), Teladoc Health Inc (TDOC) (+91.6% shares), Sempra (SRE) (+62.3% shares) and Centerspace (CSR) (+53.5% shares), compared with its Q1 2026 filing.

What did Voss Capital, LP sell last quarter?

In Q2 2026, Voss Capital, LP sold all of Sensient Technologies Corp (SXT), sold all of Xeris Biopharma Holdings Inc (XERS), sold all of Alexandria Real Estate Eq in (ARE), sold all of Acadia Healthcare Company in (ACHC), sold all of Regenxbio Inc (RGNX), Pebblebrook Hotel Tr (PEB) (-89.3% shares), Powell Inds Inc (POWL) (-85.3% shares) and Century Communities Inc (CCS) (-79.2% shares), compared with its Q1 2026 filing.

How has Voss Capital, LP's portfolio performed?

A portfolio copying Voss Capital, LP's 20 largest 13F holdings each quarter, from the day each filing was public, returned +20.8% a year over the last 3 years, against +22.3% for the S&P 500. Over 1 year: +10.9% against +11.7%. Over 5 years: +12.8% a year against +10.6%.

When is Voss Capital, LP's next 13F filing due?

13F filings are due 45 days after each quarter ends. Voss Capital, LP's filing for the quarter ending Sep 30, 2026 is due by Nov 14, 2026; this page updates the day after it is published.

How much money does Voss Capital, LP manage?

Voss Capital, LP reported $1.9B of regulatory assets under management on its latest SEC Form ADV. Its 13F, which covers only US-listed stocks and options, totals $2.0B.